Economics at your fingertips  

Economic evaluation of cystic fibrosis screening: A Review of the literature, CHERE Working Paper 2006/6

Muralikrishnan Radhakrishnan, Kees van Gool (), Jane Hall, Martin Delatycki and John Massie
Additional contact information
Muralikrishnan Radhakrishnan: CHERE, University of Technology, Sydney
Kees van Gool: CHERE, University of Technology, Sydney
Martin Delatycki: Royal Children's Hopsital, Melbourne
John Massie: Royal Children's Hopsital, Melbourne

Working Papers from CHERE, University of Technology, Sydney

Abstract: Objectives: To critically examine the economic evidence on Cystic Fibrosis (CF) screening and to understand issues relating to the transferability of findings to the Australian context for policy decisions. Methods: A systematic literature search identified 25 economic studies with empirical results on CF published between 1990 and 2005. These articles were then assessed against international benchmarks on conducting and reporting of economic evaluations, focusing on the transferability of the evidence to the local setting. Results: Six studies described only costs, 12 were cost-effectiveness studies, 6 were cost-benefit studies and one had a combined design (cost utility, cost benefit and cost effectiveness). Most of the cost-effectiveness studies compared screening versus ?no-screening? but the screening programs under consideration differed markedly. Four considered neonatal screening, three prenatal screening, three pre-conception and carrier screening, and one considered all types of screening programs. The outcome measures also varied considerably between studies. One study included a quality adjusted life year measure. Cost?benefit measures mostly included economic savings ? evaded lifetime medical costs of avoiding CF child birth. Conclusion: The variability in study design, model inputs and reporting of economic evaluations of CF carrier screening raises issues on the applicability and transferability of such evidence to the Australian context.

Keywords: Cystic fibrosis; economic evaluation (search for similar items in EconPapers)
JEL-codes: I19 (search for similar items in EconPapers)
Date: 2006-09
New Economics Papers: this item is included in nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link) First version, September, 2006 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this paper

More papers in Working Papers from CHERE, University of Technology, Sydney Contact information at EDIRC.
Bibliographic data for series maintained by Liz Chinchen ( this e-mail address is bad, please contact ).

Page updated 2024-02-26
Handle: RePEc:her:chewps:2006/6